Having launched to the consumer market in 2020, the company has over 125K customers and growing. The company has 14 issued domestic and international patents with 23 active applications ongoing, including an issued patent to reduce adverse effects when combined with a medication, therapy, or procedure.

Apollo is pursuing FDA clearance and is expanding into partnerships with pharmaceutical companies in 2025. Of note, Apollo has a LOI in hand from a $200B+ pharmaceutical company for a co-branding/ co-marketing campaign in 2025.